Press release
Comprehensive Egrifta (Tesamorelin Acetate) Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034
Egrifta Tesamorelin Acetate Market
The surge in human immunodeficiency virus (HIV) incidences is substantially spurring the expansion of the egrifta (tesamorelin acetate) market going forward. HIV cases encompass situations where people are infected with HIV, thereby steadily eroding their immune response. The increasing occurrence of HIV can be attributed in part to inadequate awareness and understanding regarding preventive strategies, such as the use of condoms and frequent testing, especially among populations at higher risk. Egrifta prompts the secretion of growth hormone, which assists in reducing surplus visceral fat and enhancing body structure, consequently amplifying the total health and life quality for those living with HIV. For instance, as reported by the Minnesota Department of Health, a health agency based in the US, in May 2024, there were 324 fresh HIV diagnoses in 2023, reflecting a 24% increase from 2022. Thus, the surging prevalence of HIV cases is fuelling the growth of the egrifta (tesamorelin acetate) industry.
Get Your Egrifta (Tesamorelin Acetate) Market Report Here:
https://www.thebusinessresearchcompany.com/report/egrifta-tesamorelin-acetate-global-market-report
What Is the projected market size and growth rate for the egrifta (tesamorelin acetate) market?
In recent years, the egrifta (tesamorelin acetate) Market has seen sizeable expansion with a HCAGR of XX. From 2024 to 2025, its projected growth is from $XX million to $XX million, with a compound annual growth rate (CAGR) of XX%. This historic growth pattern can be associated with a rising understanding of HIV-related complications, an escalated demand for drug treatment, the progressively frequent use of antiretroviral therapy, a heightened emphasis on quality of life, advancements in medical research and increasing awareness.
In the forthcoming years, the egrifta (tesamorelin acetate) market size is projected to experience an XX (FCAGR). By 2029, the market is predicted to expand to a worth of $XX million, with a compound annual growth rate (CAGR) of XX%. This growth during the forecast period can be associated with rising incidences of chronic diseases, the surge in hospital numbers, growing demand for sophisticated health monitoring systems, increasing occurrence of metabolic disorders, and heightened consciousness about disease treatment. Key trends for the forecast period encompass the escalating adoption of targeted treatment methods, integration into extensive care strategies, advancement in personalized healthcare, improvement in patient assistance initiatives, and increasing research activities.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20043&type=smp
What new trends are reshaping the egrifta (tesamorelin acetate) market and its opportunities?
A primary trend in the egrifta (tesamorelin acetate) market revolves around the continued development of advanced synthetic peptide drugs that improve the efficacy of treatments for HIV-related lipodystrophy. These synthetic peptide drugs are artificially created compounds which aim to provide specific therapeutic benefits by mimicking or enhancing the function of peptides found naturally. As an example, there was an announcement by Canada's Theratechnologies Inc., a biopharmaceutical firm, in December 2024 stating that the production of EGRIFTA SV has recommenced following a voluntary shutdown of its manufacturer's facility, spurred by FDA inspection observations. After passing quality control, a freshly produced batch will be released once a prior approval supplement from the US Food and Drug Administration (FDA) is approved and two more batches are currently in production. To satisfy patient needs until mid-January 2025, the company is handling inventory and collaborating with the FDA to avoid a shortage in 2025. EGRIFTA SV is only distributed within the US.
What major market segments define the scope and growth of the egrifta (tesamorelin acetate) market?
The egrifta (tesamorelin acetate) market covered in this report is segmented -
1) By Clinical Indication: Human Immunodeficiency Virus (HIV)-Associated Lipodystrophy, Growth Hormone Deficiency, Abdominal Obesity, Metabolic Syndrome
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
3) By End-Users: Hospitals, Specialized Clinics, Home Care
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20043
Which region dominates the egrifta (tesamorelin acetate) market?
North America was the largest region in the egrifta (tesamorelin acetate) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the egrifta (tesamorelin acetate) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Which key market leaders are driving the egrifta (tesamorelin acetate) industry growth?
Major companies operating in the egrifta (tesamorelin acetate) market include Theratechnologies Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20043&type=smp
What Is Covered In The Egrifta (Tesamorelin Acetate) Global Market Report?
•Market Size Forecast: Examine the egrifta (tesamorelin acetate) market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the egrifta (tesamorelin acetate) market for a structured understanding.
•Key Players Overview: Analyze major players in the egrifta (tesamorelin acetate) market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the egrifta (tesamorelin acetate) market.
•Segment Contributions: Evaluate how different segments drive overall growth in the egrifta (tesamorelin acetate) market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the egrifta (tesamorelin acetate) market.
•Industry Challenges: Identify potential risks and obstacles affecting the egrifta (tesamorelin acetate) market.
•Competitive Landscape: Review strategic developments in the egrifta (tesamorelin acetate) market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Comprehensive Egrifta (Tesamorelin Acetate) Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034 here
News-ID: 3937773 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for HIV
HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792
This latest report researches the industry structure, sales, revenue,…
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
